메뉴 건너뛰기




Volumn 143, Issue 4, 2012, Pages 887-889

Data to guide the "test and treat era" of hepatitis C

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE INHIBITOR;

EID: 84866695910     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.08.027     Document Type: Editorial
Times cited : (8)

References (18)
  • 1
    • 33748114343 scopus 로고    scopus 로고
    • The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
    • J.F. Perz, G.L. Armstrong, L.A. Farrington The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 2006 529 538
    • (2006) J Hepatol , vol.45 , pp. 529-538
    • Perz, J.F.1    Armstrong, G.L.2    Farrington, L.A.3
  • 2
    • 79953171086 scopus 로고    scopus 로고
    • Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection
    • F. Kanwal, T. Hoang, J.R. Kramer Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection Gastroenterology 140 2011 1182 1188
    • (2011) Gastroenterology , vol.140 , pp. 1182-1188
    • Kanwal, F.1    Hoang, T.2    Kramer, J.R.3
  • 3
    • 84857144025 scopus 로고    scopus 로고
    • The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007
    • K.N. Ly, J. Xing, R.M. Klevens The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007 Ann Intern Med 156 2012 271 278
    • (2012) Ann Intern Med , vol.156 , pp. 271-278
    • Ly, K.N.1    Xing, J.2    Klevens, R.M.3
  • 4
    • 78649949431 scopus 로고    scopus 로고
    • Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States
    • D.B. Rein, J.S. Wittenborn, C.M. Weinbaum Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States Dig Liver Dis 43 2011 66 72
    • (2011) Dig Liver Dis , vol.43 , pp. 66-72
    • Rein, D.B.1    Wittenborn, J.S.2    Weinbaum, C.M.3
  • 5
    • 79959438789 scopus 로고    scopus 로고
    • Telaprevir for previously untreated chronic hepatitis C virus infection
    • I. Jacobson, J. McHutchison, G. Dusheiko Telaprevir for previously untreated chronic hepatitis C virus infection N Engl J Med 364 2011 2405 2416
    • (2011) N Engl J Med , vol.364 , pp. 2405-2416
    • Jacobson, I.1    McHutchison, J.2    Dusheiko, G.3
  • 6
    • 79953173221 scopus 로고    scopus 로고
    • Boceprevir for untreated chronic HCV genotype 1 infection
    • F. Poordad, J. McCone, B. Bacon Boceprevir for untreated chronic HCV genotype 1 infection N Engl J Med 364 2011 1195 1206
    • (2011) N Engl J Med , vol.364 , pp. 1195-1206
    • Poordad, F.1    McCone, J.2    Bacon, B.3
  • 7
    • 84855209804 scopus 로고    scopus 로고
    • Direct acting antivirals for the treatment of chronic hepatitis C: One pill a day for tomorrow
    • T. Asselah, P. Marcellin Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow Liver Int 32 Suppl 1 2012 S88 S102
    • (2012) Liver Int , vol.32 , Issue.SUPPL. 1
    • Asselah, T.1    Marcellin, P.2
  • 8
    • 79957497436 scopus 로고    scopus 로고
    • A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C
    • L.I. Backus, D.B. Boothroyd, B.R. Phillips A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C Clin Gastroenterol Hepatol 9 2011 509 516
    • (2011) Clin Gastroenterol Hepatol , vol.9 , pp. 509-516
    • Backus, L.I.1    Boothroyd, D.B.2    Phillips, B.R.3
  • 9
    • 75349096812 scopus 로고    scopus 로고
    • Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
    • A.K. Singal, A. Singh, S. Jaganmohan Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis Clin Gastroenterol Hepatol 8 2010 192 199
    • (2010) Clin Gastroenterol Hepatol , vol.8 , pp. 192-199
    • Singal, A.K.1    Singh, A.2    Jaganmohan, S.3
  • 11
    • 84866672248 scopus 로고    scopus 로고
    • Predicted effects of treatment for HCV infection vary among European countries
    • S. Deuffic-Burban, P. Deltenre, M. Buti Predicted effects of treatment for HCV infection vary among European countries Gastroenterology 143 2012 974 985
    • (2012) Gastroenterology , vol.143 , pp. 974-985
    • Deuffic-Burban, S.1    Deltenre, P.2    Buti, M.3
  • 12
    • 84859947750 scopus 로고    scopus 로고
    • Economic model of a birth cohort screening program for hepatitis C virus
    • L.J. McGarry, V.S. Pawar, H.R. Panchmatia Economic model of a birth cohort screening program for hepatitis C virus Hepatology 555 2012 1344 1355
    • (2012) Hepatology , vol.555 , pp. 1344-1355
    • McGarry, L.J.1    Pawar, V.S.2    Panchmatia, H.R.3
  • 13
    • 84863393363 scopus 로고    scopus 로고
    • The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings
    • D.B. Rein, B.D. Smith, J.S. Wittenborn The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings Ann Intern Med 156 2012 263 270
    • (2012) Ann Intern Med , vol.156 , pp. 263-270
    • Rein, D.B.1    Smith, B.D.2    Wittenborn, J.S.3
  • 14
    • 84859773755 scopus 로고    scopus 로고
    • Cost-effectiveness and population outcomes of general population screening for hepatitis C
    • P.O. Coffin, J.D. Scott, M.R. Golden Cost-effectiveness and population outcomes of general population screening for hepatitis C Clin Infect Dis 54 2012 1259 1271
    • (2012) Clin Infect Dis , vol.54 , pp. 1259-1271
    • Coffin, P.O.1    Scott, J.D.2    Golden, M.R.3
  • 15
    • 84863116884 scopus 로고    scopus 로고
    • New protease inhibitors for the treatment of chronic hepatitis C: A cost-effectiveness analysis
    • S. Liu, L.E. Cipriano, M. Holodniy New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis Ann Intern Med 156 2012 279 290
    • (2012) Ann Intern Med , vol.156 , pp. 279-290
    • Liu, S.1    Cipriano, L.E.2    Holodniy, M.3
  • 16
    • 84867288022 scopus 로고    scopus 로고
    • Recommendations for the identification of chronic hepatitis C virus (HCV) among persons born during 1945-1965
    • CDC
    • CDC Recommendations for the identification of chronic hepatitis C virus (HCV) among persons born during 1945-1965 MMWR 61 No. RR-4 2012 1 32
    • (2012) MMWR , vol.61 , Issue.RR-4 , pp. 1-32
  • 17
    • 79960369225 scopus 로고    scopus 로고
    • Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates)
    • P.L. Almasio, S. Babudieri, G. Barbarini Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) Dig Liver Dis 43 2011 589 595
    • (2011) Dig Liver Dis , vol.43 , pp. 589-595
    • Almasio, P.L.1    Babudieri, S.2    Barbarini, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.